Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00018343

Enrollment

Unknown

Registered

2001-07-05

Start date

1998-04-30

Completion date

2001-03-31

Last updated

2009-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Brief summary

This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.

Interventions

DRUGestrogen

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE

Eligibility

Sex/Gender

FEMALE

Age

50 Years to 90 Years

Healthy volunteers

Inclusion criteria

* Post menopausal women with alzheimer's disease * free of any major medical or neurological disease, * medically safe to be treated with estrogen.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026